Institutional investors hold a majority ownership of BCR through the 91.45% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Medical Specialties industry. Last, during the quarter ended December 2016, these large investors purchased a net $411.8 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CITADEL ADVISORS LLC Bought 545.5 Thousand shares of C R Bard Inc
ALYESKA INVESTMENT GROUP LP Bought 379.3 Thousand shares of C R Bard Inc
JENNISON ASSOCIATES LLC Bought 194.6 Thousand shares of C R Bard Inc